International experts discuss antimicrobial resistance and superbugs
The forum was organized by bioMérieux, a company that specializes in the field of in vitro diagnostics and microbiology. BioMérieux is present in more than 150 countries and was founded in France.
One of the major issues looked at during the forum was antimicrobial resistance. Antimicrobial resistance has been recognized as a major global public health challenge. Some of the issues that result from antimicrobial resistance are high morbidity and mortality rates, along with significant additional healthcare spending.
Recent warnings of superbugs have come from the G81 summit and Director of the U.S. Centers for Disease Control and Prevention Thomas Frieden.
During the forum, experts from around the world agreed on various actions to fight these superbugs. BioMérieux also agreed to these actions and said it would assess the global burden of superbugs and carry out a multi-center interventional study.
BioMérieux estimates that the initial results of these studies should be completed within 18 months, and said it will continue to invest in research and development in order to fight these infectious diseases.